Mary Kay Ladone, Director at KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS), sold 3,908 shares at $25.20 ($98K) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Open-market sale of $98k KMTS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HRC | SELL | 2021-07-30 | $1.2M | — | Filing → |
| HRC | SELL | 2021-07-27 | $1.0M | — | Filing → |
| HRC | SELL | 2020-07-02 | $251K | — | Filing → |